Marketing-authorisation holder · Canada
Accord Healthcare Inc
209 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Canada
209 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 209
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACH-ALENDRONATE10 mg · Tablet | Alendronic acid | Canada | Marketed | 2012 |
| ACH-ALENDRONATE70 mg · Tablet | Alendronic acid | Canada | Marketed | 2012 |
| ACH-ALENDRONATE5 mg · Tablet | Alendronic acid | Canada | Not marketed | 2012 |
| ACH-AMLODIPINE5 mg · Tablet | Amlodipine | Canada | Marketed | 2018 |
| ACH-AMLODIPINE10 mg · Tablet | Amlodipine | Canada | Marketed | 2018 |
| ACH-AMLODIPINE2.5 mg · Tablet | Amlodipine | Canada | Marketed | 2018 |
| ACH-ANASTROZOLE1 mg · Tablet | Anastrozole | Canada | Marketed | 2012 |
| ACH-APIXABAN5 mg · Tablet | Apixaban | Canada | Marketed | 2022 |
| ACH-APIXABAN2.5 mg · Tablet | Apixaban | Canada | Marketed | 2022 |
| ACH-ATORVASTATIN CALCIUM20 mg · Tablet | Atorvastatin | Canada | Marketed | 2019 |
| ACH-ATORVASTATIN CALCIUM40 mg · Tablet | Atorvastatin | Canada | Marketed | 2019 |
| ACH-ATORVASTATIN CALCIUM80 mg · Tablet | Atorvastatin | Canada | Marketed | 2019 |
| ACH-ATORVASTATIN CALCIUM10 mg · Tablet | Atorvastatin | Canada | Marketed | 2019 |
| ACH-BICALUTAMIDE50 mg · Tablet | Bicalutamide | Canada | Marketed | 2010 |
| ACH-CANDESARTAN16 mg · Tablet | Candesartan cilexetil | Canada | Not marketed | 2012 |
| ACH-CANDESARTAN8 mg · Tablet | Candesartan cilexetil | Canada | Not marketed | 2012 |
| ACH-CANDESARTAN32 mg · Tablet | Candesartan cilexetil | Canada | Not marketed | 2012 |
| ACH-CAPECITABINE150 mg · Tablet | Capecitabine | Canada | Marketed | 2014 |
| ACH-CAPECITABINE500 mg · Tablet | Capecitabine | Canada | Marketed | 2014 |
| ACH-DONEPEZIL10 mg · Tablet | Donepezil | Canada | Marketed | 2013 |
| ACH-DONEPEZIL5 mg · Tablet | Donepezil | Canada | Marketed | 2013 |
| ACH-ESCITALOPRAM20 mg · Tablet | Escitalopram | Canada | Marketed | 2016 |
| ACH-ESCITALOPRAM10 mg · Tablet | Escitalopram | Canada | Marketed | 2016 |
| ACH-EZETIMIBE10 mg · Tablet | Ezetimibe | Canada | Marketed | 2014 |
| ACH-FESOTERODINE4 mg · Tablet (Extended-Release) | Fesoterodine | Canada | Marketed | 2026 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 209 | 164 | 45 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.